ライフサイエンスコーパス: breast reconstruction

1 period, of which 9315 (19.2%) had immediate breast reconstruction.

2 to combine this new method with the standard breast reconstruction.

3 atients after immediate unilateral DIEP flap breast reconstruction.

4 ticenter prospective longitudinal studies in breast reconstruction.

5 n that minority women have limited access to breast reconstruction.

6 g of the abdomen before undergoing DIEP flap breast reconstruction.

7 or ethnicity, appear to influence the use of breast reconstruction.

8 e number of radiated patients presenting for breast reconstruction.

9 economic characteristics are associated with breast reconstruction.

10 atient-reported outcomes following immediate breast reconstruction.

11 o undergo immediate or delayed implant-based breast reconstruction.

12 th shaping these women's perspectives toward breast reconstruction.

13 lgorithms can accurately predict PROs before breast reconstruction.

14 or breast cancer, mastectomy, and autologous breast reconstruction.

15 t-based and 647 (28.7%) underwent autologous breast reconstruction.

16 applied in both autologous and implant-based breast reconstruction.

17 s with or without implant- or expander-based breast reconstruction.

18 between hospitals following post-mastectomy breast reconstruction.

19 ects of their care when making decisions for breast reconstruction.

20 e strongly associated with direct-to-implant breast reconstruction.

21 ons for PMRT, including those with immediate breast reconstruction.

22 respect to pre-pectoral versus sub-pectoral breast reconstruction.

23 re has been a transition toward pre-pectoral breast reconstruction.

24 optimal approach to immediate implant-based breast reconstruction.

25 making is needed to support decisions about breast reconstruction.

26 ssess the quality of patient decisions about breast reconstruction.

27 ence cost variation for autologous free flap breast reconstruction.

28 tralateral prophylactic mastectomy (CPM) and breast reconstruction.

29 ong patients undergoing autologous free flap breast reconstruction.

30 orted outcomes (PROs) in patients undergoing breast reconstruction.

31 and sexual well-being in patients undergoing breast reconstruction.

32 st cancer and underwent autologous free flap breast reconstruction.

33 luate temporal trends in receipt of PMRT and breast reconstruction.

34 ursuing mastectomy, which may be followed by breast reconstruction.

35 autologous (AT), and direct-to-implant (DI) breast reconstruction.

36 e tissue donated by healthy women undergoing breast reconstruction.

37 mastectomy for breast cancer do not undergo breast reconstruction.

38 rgoing mastectomy with and without immediate breast reconstruction.

39 ergoing mastectomy with or without immediate breast reconstruction.

40 tion and in those undergoing tissue expander breast reconstruction.

41 ads to decreased flap survival in autologous breast reconstruction.

42 east cancers in autogenous myocutaneous flap breast reconstructions.

43 Three patients dropped out (2 who underwent breast reconstruction [1 in the app group, 1 in the cont

44 cision tool that: 1) educates patients about breast reconstruction; 2) estimates personalized risk of

45 my and 9215 patients who received autologous breast reconstruction, 36 777 (67%) were White and 32 20

46 l and patient-reported outcomes of immediate breast reconstruction after mastectomy at 11 leading med

47 Although immediate breast reconstruction after mastectomy has become routin

48 luded women 18 years or older presenting for breast reconstruction after mastectomy with 2 years or m

49 outcome measures include temporal trends in breast reconstruction and bilateral mastectomy for unila

50 ve recovery between the 2 groups (lymphedema breast reconstruction and breast reconstruction) were co

51 d with simultaneous bilateral TRAM free flap breast reconstruction and describe refinements in its su

52 toperative follow-up for patients undergoing breast reconstruction and gynecologic oncology surgery u

53 n the patients undergoing mastectomy without breast reconstruction and in those undergoing tissue exp

54 h validated scales to assess knowledge about breast reconstruction and involvement in decision making

55 a cost-effective alternative to sub-pectoral breast reconstruction and may confer cost benefit, as it

56 ing clinician comfort with irradiating a new breast reconstruction and may have cosmetic and quality-

57 As the use of breast reconstruction and postmastectomy radiotherapy (P

58 view of available literature on the topic of breast reconstruction and radiation is presented.

59 st cancer patients to enhance the quality of breast reconstruction and the related risks.

60 BCS-eligible patients undergoing mastectomy, breast reconstruction, and bilateral mastectomy.

61 ate their natural breast, mastectomy site or breast reconstruction, and external silicone models.

62 efore and after delayed unilateral DIEP flap breast reconstruction, and on four patients after immedi

63 ng or skin-sparing mastectomy with immediate breast reconstruction, and to recommend appropriate rese

64 s influencing the decision-making process in breast reconstruction are analyzed.

65 edures, including unplanned revisions, after breast reconstruction are common and vary by reconstruct

66 al morbidity, especially when mastectomy and breast reconstruction are done for widespread low-grade

67 Complications after immediate implant-based breast reconstruction are higher than recommended by nat

68 on morbidity after mastectomy with immediate breast reconstruction are limited.

69 New trends of immediate breast reconstruction are presented.

70 urpose The goals of immediate postmastectomy breast reconstruction are to minimize deformity and opti

71 55 mastectomies with immediate implant-based breast reconstruction at 81 units across the UK.

72 , 2015, among ambulatory patients undergoing breast reconstruction at an academic ambulatory care hos

73 Breast reconstruction at any time after mastectomy and p

74 e, and BREAST-Q scores from women undergoing breast reconstruction at Memorial Sloan Kettering Cancer

75 sition for breast cancer receiving immediate breast reconstruction at the time of mastectomy were inc

76 Primary outcomes included use of autologous breast reconstruction before and after expansion.

77 bstracts identified in the field of HRQoL in breast reconstruction between 1978 and 2009.

78 improve outcomes of immediate implant-based breast reconstruction-breast reconstruction with implant

79 SSI and implant removal after implant-based breast reconstruction but comes with a higher risk of ad

80 kin-sparing mastectomy facilitates immediate breast reconstruction by reducing remedial surgery on th

81 y before mastectomy and autologous free-flap breast reconstruction can avoid adverse radiation effect

82 Although postmastectomy breast reconstruction can restore quality of life and bo

83 Patients undergoing ambulatory breast reconstruction can use follow-up care via a mobil

84 risk of lymphedema associated with immediate breast reconstruction compared to mastectomy alone.

85 nts who received a lipofilling procedure for breast reconstruction compared with controls.

86 t muscle fibrosis is the main contributor of breast reconstruction contracture after radiation.

87 risk for breast cancer if autogenous tissue breast reconstruction could be performed with reasonable

88 BREASTChoice can improve breast reconstruction decision quality by improving pati

89 dy results suggest that commercial rates for breast reconstruction demonstrated large nationwide vari

90 sed to prevent infection after implant-based breast reconstruction despite the lack of high-level evi

91 Complication risks after immediate breast reconstruction differ by approach.

92 0% of women experience dissatisfaction after breast reconstruction due to unexpected outcomes that ar

93 r, how acellular dermal matrix (ADM) used in breast reconstruction elicits an attenuated foreign-body

94 e complications related to flap survival for breast reconstruction, especially in obese subjects.

95 The implant Breast Reconstruction evAluation prospective cohort stud

96 ored the cost effectiveness of implant-based breast reconstruction, few investigations have evaluated

97 Overall, 42% of patients had breast reconstruction following mastectomy.

98 st cancer survivors in the US have undergone breast reconstruction following mastectomy.

99 een on the market for breast augmentation or breast reconstruction for approximately 60 years but may

100 who had any type of immediate implant-based breast reconstruction for malignancy or risk reduction,

101 rafting has proven to be a useful adjunct to breast reconstruction for the treatment of contour irreg

102 Women undergoing mastectomy and breast reconstruction for unilateral breast cancer were

103 All patients who underwent implant-based breast reconstruction from 1991 to 2017 were retrospecti

104 omen who underwent mastectomy with immediate breast reconstruction from 2008 to 2009.

105 ergoing mastectomy with or without immediate breast reconstruction from January 1, 2005, through Dece

106 t had no significant effect in the immediate breast reconstruction group (OR, 0.98; 95% CI, 0.79-1.23

107 ation time was 426 minutes in the lymphedema breast reconstruction group and 391 minutes in the breas

108 reconstruction group and 391 minutes in the breast reconstruction group.

109 showed radiotherapy after direct-to-implant breast reconstruction had a lower rate of complications

110 Although breast reconstruction has been shown to confer significa

111 Breast reconstruction has increased over time, but it ha

112 f HF after mastectomy in patients undergoing breast reconstruction has not been prospectively examine

113 al approach to integrating radiotherapy with breast reconstruction has provoked intense controversy i

114 Breast reconstruction has the potential to improve a per

115 on between Medicaid expansion and autologous breast reconstruction has yet to be performed.

116 tion of these technologies in the setting of breast reconstruction have arisen.

117 Most studies of complications after breast reconstruction have been conducted at centers of

118 Racial disparities influencing breast reconstruction have been well-researched; however

119 elopments in oncoplastic surgery and partial-breast reconstruction have improved cosmetic outcomes af

120 30 years, significant technical advances in breast reconstruction have increased performance of this

121 Variations in who undergoes breast reconstruction have led to questions about the qu

122 women who underwent immediate implant-based breast reconstruction (IBBR) after receiving either: (1)

123 ellular dermal matrix (ADM) in implant-based breast reconstructions (IBBRs) is established practice.

124 Immediate breast reconstruction (IBR) after mastectomy for cancer

125 y sensitive to measure changes consequent to breast reconstruction (ie, effect on body image or psych

126 on while achieving the benefits of immediate breast reconstruction (IMBR).

127 Few studies have examined whether breast reconstruction impacts development of lymphedema.

128 by this pattern may be a mechanism by which breast reconstruction improves self-perception, and thus

129 2010, we performed free lower abdominal flap breast reconstruction in 87 patients.

130 p inferior epigastric perforator (DIEP) flap breast reconstruction in an attempt to better understand

131 e complications after implant and autologous breast reconstruction in patients undergoing unilateral

132 t WAT-derived cells used in lipotransfer for breast reconstruction in patients with breast cancer.

133 rted outcomes after unilateral and bilateral breast reconstruction in patients with unilateral breast

134 y objective was to characterize the price of breast reconstruction in relation to market concentratio

135 insured female patients undergoing immediate breast reconstruction in the 2009 to 2011 Nationwide Inp

136 bout women's attitudes and perceptions about breast reconstruction in the African context.

137 the optimal integration of radiotherapy and breast reconstruction in the management of breast cancer

138 and clinicians make informed decisions about breast reconstruction in the setting of chemotherapy.

139 Breast reconstruction increased across all cohorts.

140 y, although the odds of receiving autologous breast reconstruction increased annually, Medicaid expan

141 In women undergoing mastectomy, rates of breast reconstruction increased from 11.6% in 1998 to 36

142 This study suggests that pre-pectoral breast reconstruction is a cost-effective alternative to

143 Breast reconstruction is an important treatment option f

144 Immediate breast reconstruction is associated with a statistically

145 Breast reconstruction is associated with high levels of

146 Breast reconstruction is costly, and negotiated commerci

147 As prepectoral breast reconstruction is gaining popularity, there have

148 regarding the incidence of SSI in immediate breast reconstruction is highly variable and series depe

149 Immediate breast reconstruction is increasingly performed at the t

150 whom RT could be avoided or mastectomy with breast reconstruction is indicated.

151 This study suggest that prepectoral breast reconstruction is safe in an irradiated patient p

152 The goal of post-mastectomy breast reconstruction is to restore body image and quali

153 hospital variation for autologous free flap breast reconstruction is unknown.

154 vasive carcinoma underwent SSM and immediate breast reconstruction (June 1986 to December 1997).

155 ion during autologous fat transplantation in breast reconstruction, little is known about its mechani

156 Breast reconstruction may improve quality-of-life sequel

157 patients included in the trial, 36 underwent breast reconstruction (mean [SD] age, 45.30 [9.13] years

158 ys in TTC included low socioeconomic status, breast reconstruction, nonprivate insurance, and Hispani

159 y in the group undergoing mastectomy without breast reconstruction (odds ratio [OR], 0.80; 95% CI, 0.

160 Women undergoing immediate breast reconstruction often require chemotherapy.

161 s a common adverse outcome following implant breast reconstruction, often associated with radiation t

162 There is a need for a new, less invasive breast reconstruction option for patients who undergo ma

163 ciated with patients' recollections of their breast reconstruction options after discussions with the

164 t patients remember from consultations about breast reconstruction options.

165 men older than 18 years undergoing oncologic breast reconstruction or major gynecologic oncology surg

166 (OR, 0.59; 95% CI, 0.48-0.72), any immediate breast reconstruction (OR, 0.57; 95% CI, 0.37-0.88), and

167 0.59; 95% CI, 0.49-0.71), mastectomy without breast reconstruction (OR, 0.59; 95% CI, 0.48-0.72), any

168 y in the group undergoing mastectomy without breast reconstruction (OR, 0.61; 95% CI, 0.51-0.73) and

169 support the need for additional longitudinal breast reconstruction outcome studies.

170 ients were recruited as part of the Michigan Breast Reconstruction Outcome Study, a 12 center, 23 sur

171 rmine and compare surgical, oncological, and breast reconstruction outcomes, including quality of lif

172 approach may be preferable to mastecomy and breast reconstruction, particularly when postmastectomy

173 antial healthcare charges to the care of the breast reconstruction patient.

174 more attention has focused on postmastectomy breast reconstruction (PBR).

175 short-term safety of immediate implant-based breast reconstruction performed with and without mesh, t

176 The immediate breast reconstruction population included 19,258 patient

177 Machine learning may inform PROs in breast reconstruction, possibly enhancing shared decisio

178 all radiotherapy in the context of immediate breast reconstruction present special challenges.

179 Breast reconstruction pricing should be analyzed to eval

180 n Cancer Center were asked to indicate which breast reconstruction procedures they discussed with the

181 bias was not associated with disparities in breast reconstruction rates, complications, or cost.

182 triple-antibiotic implant irrigation during breast reconstruction receive adequate prophylaxis for S

183 monstrated psychosocial benefits, autologous breast reconstruction remains underutilized.

184 positioning of implants during implant-based breast reconstruction should ideally be investigated by

185 sks associated with the use of WAT cells for breast reconstructions should be better investigated ret

186 Breast reconstruction studies increasingly aim to assess

187 d by the BREAST-Q questionnaire, a validated breast reconstruction surgery questionnaire.

188 e lowest after expander and highest after AT breast reconstruction (TE = 6.5% [reference] vs AT = 13.

189 andomised clinical trial comparing different breast reconstruction techniques.

190 de a safe oncologic procedure with immediate breast reconstruction that could technically be applied

191 ved stem cells (ADSC), e.g. lipotransfer for breast reconstruction, this study aimed to gain novel in

192 bias was not associated with differences in breast reconstruction utilization, complications, or cos

193 Third, opinions on breast reconstruction varied between perceiving reconstr

194 The mean cost for autologous free flap breast reconstruction was $22677 (interquartile range, $

195 s who underwent mastectomy and implant-based breast reconstruction was performed from 2017 to 2020.

196 nt 240 simultaneous bilateral TRAM free flap breast reconstructions was developed.

197 with a subpectoral tissue expander, and in 6 breasts, reconstruction was performed with a DIEP flap.

198 In 40 breasts, reconstruction was performed with a subpectoral

199 h ADM) collected from individuals undergoing breast reconstruction, we show that high levels of the e

200 of 34 papers that included HRQL outcomes in breast reconstruction were identified and reviewed in de

201 [10.6] years) 18 years or older who desired breast reconstruction were included, of whom 91 patients

202 Perspectives, attitudes, and perceptions on breast reconstruction were obtained using semi-structure

203 ho had undergone mastectomy and were seeking breast reconstruction were screened for eligibility (rad

204 First, women's perceptions toward breast reconstruction were shaped by a balance of breast

205 groups (lymphedema breast reconstruction and breast reconstruction) were compared.

206 ns have led to an increased use of immediate breast reconstruction, which has resulted in uncertainty

207 ess acculturated Latinas, had low receipt of breast reconstruction, which may be related to limited i

208 regarding breast cancer patients' access to breast reconstruction, which provides important psychoso

209 adverse effects of radiotherapy on the final breast reconstruction while achieving the benefits of im

210 , among 40 patients undergoing implant-based breast reconstruction who were part of the ongoing BREAS

211 Breast reconstruction with AFT plus expansion or 2-phase

212 III breast cancer considering postmastectomy breast reconstruction with no previous reconstruction we

213 66,593 (77.6%) underwent mastectomy without breast reconstruction, with 2876 (4.3%) receiving NC; 78

214 ith radiation therapy (RT) or mastectomy and breast reconstruction without RT.

215 g stable in other cohorts and (2) receipt of breast reconstruction would decrease in these women whil